DSpace at RU >

Browsing by Author Bos, J.D.

Full Text	Issue Date	Title	Author(s)
	2010	Extent and clinical consequences of antibody formation against adalimumab in patients with plaque psoriasis.	Lecluse, L.L.; Driessen, R.J.B.; Spuls, P.I.; Jong, E.M.G.J. de; Stapel, S.O., et al
	2009	European S3-guidelines on the systemic treatment of psoriasis vulgaris.	Pathirana, D.; Ormerod, A.D.; Saiag, P.; Smith, C.; Spuls, P.I., et al
	2006	Human keratinocytes produce the complement inhibitor factor H: synthesis is regulated by interferon-gamma.	Timar, K.K.; Pasch, M.C.; Bosch, N.H. van den; Jarva, H.; Junnikkala, S., et al
	2004	Biological therapies in the systemic management of psoriasis : International Consensus Conference	Sterry, W.; Barker, J.; Boehncke, W.H.; Bos, J.D.; Chimenti, S., et al
	2004	In situ demonstration of CD40- and CD154-positive cells in psoriatic lesions and keratinocyte production of chemokines by CD40 ligation in vitro.	Pasch, M.C.; Timar, K.K.; Meurs, M. van; Heydendael, V.M.; Bos, J.D., et al
	1997	A multicentre evaluation of the guidelines for the use of cyclosporin A in severe psoriasis	Witkamp, L.; Meinardi, M.M.H.M.; Bossuyt, P.M.; Kerkhof, P.C.M. van de; Arnold, W.P., et al
	1996	A multicentre evaluation of the guidelines for the use of cyclosporin A in severe psoriasis	Witkamp, L.; Meinardi, M.M.H.M.; Bossuyt, P.M.; Kerkhof, P.C.M. van de; Arnold, W.P., et al
	1995	Pathogenic aspets of psoriasis. Introduction	Kerkhof, P.C.M. van de; Bos, J.D.